Oppenheimer & Co. Inc. acquired a new stake in shares of Arcosa, Inc. (NYSE:ACA – Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 6,887 shares of the company’s stock, valued at approximately $645,000.
A number of other institutional investors and hedge funds have also made changes to their positions in ACA. Norges Bank purchased a new stake in shares of Arcosa during the 2nd quarter valued at about $49,475,000. Vaughan Nelson Investment Management L.P. bought a new stake in Arcosa during the third quarter worth approximately $37,035,000. Bank of America Corp DE raised its position in Arcosa by 80.5% during the second quarter. Bank of America Corp DE now owns 465,140 shares of the company’s stock valued at $40,332,000 after purchasing an additional 207,457 shares during the period. The Manufacturers Life Insurance Company lifted its stake in shares of Arcosa by 25.3% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 763,557 shares of the company’s stock valued at $66,208,000 after purchasing an additional 154,172 shares during the last quarter. Finally, First Trust Advisors LP lifted its stake in shares of Arcosa by 29.0% in the 2nd quarter. First Trust Advisors LP now owns 617,265 shares of the company’s stock valued at $53,523,000 after purchasing an additional 138,676 shares during the last quarter. 90.66% of the stock is owned by hedge funds and other institutional investors.
Arcosa Price Performance
ACA opened at $125.24 on Wednesday. The business has a fifty day moving average of $114.38 and a 200 day moving average of $103.08. The stock has a market cap of $6.14 billion, a P/E ratio of 41.47, a PEG ratio of 1.72 and a beta of 1.00. The company has a quick ratio of 1.30, a current ratio of 2.02 and a debt-to-equity ratio of 0.61. Arcosa, Inc. has a 52-week low of $68.11 and a 52-week high of $131.00.
Arcosa Dividend Announcement
Wall Street Analysts Forecast Growth
Several equities analysts have recently weighed in on ACA shares. Wall Street Zen downgraded Arcosa from a “buy” rating to a “hold” rating in a research report on Saturday, January 10th. Barclays boosted their price objective on shares of Arcosa from $106.00 to $115.00 and gave the company an “overweight” rating in a research report on Monday, November 3rd. Finally, Weiss Ratings reissued a “buy (b-)” rating on shares of Arcosa in a research note on Monday, December 29th. Three investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $117.50.
Check Out Our Latest Analysis on Arcosa
About Arcosa
Arcosa, Inc (NYSE: ACA) is a Dallas‐based industrial company that was formed through the spin‐off of Trinity Industries’ construction products business in 2018. Since its inception, Arcosa has focused on the manufacture and sale of critical infrastructure components, serving a diverse set of end markets including transportation, construction and energy.
The company’s Construction Products segment produces a broad range of highway safety products, such as guardrail systems, sign supports and crash cushions, as well as aggregates and ready‐mix concrete.
Further Reading
- Five stocks we like better than Arcosa
- Energy Security Is Now National Security – Positioning Is Happening Now
- When to buy gold (mathematically)
- The gold chart Wall Street is terrified of…
- The “Bomb” in America’s Basement
- Unlocked: Elon Musk’s Next Big IPO
Want to see what other hedge funds are holding ACA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Arcosa, Inc. (NYSE:ACA – Free Report).
Receive News & Ratings for Arcosa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcosa and related companies with MarketBeat.com's FREE daily email newsletter.
